Certified by Founder Lodge
Goldman Sachs Asset Management
United Kingdom - London, England
INVESTOR
1 Disclosed Funding Rounds $35,000,000
35 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Bringing together traditional and alternative investments, we provide clients around the world with a dedicated partnership and focus on long-term performance. As the primary investing area w
Company | Date | Round | Raised |
---|---|---|---|
Limble CMMS | June, 22 ,2023 | Series B | $58,000,000 |
Resilia | October, 31 ,2022 | Series B | $35,000,000 |
Septerna | July, 18 ,2023 | Series B | $150,000,000 |
Mews | December, 16 ,2022 | Series C | $185,000,000 |
Fortanix | September, 15 ,2022 | Series C | $90,000,000 |
Bowery Valuation | July, 19 ,2023 | Series B | $16,300,000 |
Netskope | January, 06 ,2023 | Debt Round | $401,000,000 |
Solink | July, 26 ,2023 | Series C | $60,000,000 |
Mayvenn | July, 13 ,2022 | Series C | $40,000,000 |
Candex | November, 30 ,2023 | Series B | $45,000,000 |
Zilch | June, 30 ,2022 | Series C | $50,000,000 |
Bastille | January, 26 ,2024 | Series C | $44,000,000 |
AlphaSense | June, 15 ,2022 | Series D | $225,000,000 |
Alterome Therapeutics, Inc | April, 09 ,2024 | Series B | $132,000,000 |
MoEngage | June, 01 ,2022 | Series E | $77,000,000 |
RippleMatch | June, 12 ,2022 | Series B | $45,000,000 |
Kontakt.io | April, 19 ,2024 | Unknown | $47,500,000 |
Rimac Technology | June, 02 ,2022 | Series D | $536,000,000 |
Vicebio | September, 24 ,2024 | Series B | $100,000,000 |
WSO2 | May, 25 ,2022 | Series E | $3,000,000 |
Desia | October, 01 ,2024 | Pre-Seed | $3,300,000 |
Caribou | May, 23 ,2022 | Series C | $115,000,000 |
Mahmee | May, 12 ,2022 | Series A | $9,200,000 |
Impact Nano | May, 08 ,2023 | Unknown | $32,000,000 |
Madhive | June, 16 ,2023 | Unknown | $300,000,000 |
Limble CMMS | June, 22 ,2023 | Series B | $58,000,000 |
Septerna | July, 18 ,2023 | Series B | $150,000,000 |
Bowery Valuation | July, 19 ,2023 | Series B | $16,300,000 |
Solink | July, 26 ,2023 | Series C | $60,000,000 |
Candex | November, 30 ,2023 | Series B | $45,000,000 |
Bastille | January, 26 ,2024 | Series C | $44,000,000 |
Alterome Therapeutics, Inc | April, 09 ,2024 | Series B | $132,000,000 |
Kontakt.io | April, 19 ,2024 | Unknown | $47,500,000 |
Vicebio | September, 24 ,2024 | Series B | $100,000,000 |
Desia | October, 01 ,2024 | Pre-Seed | $3,300,000 |